)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Shanghai RAAS Blood Products
Shanghai RAAS Blood Products (002252) investor relations material
Shanghai RAAS Blood Products Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary29 Apr, 2026
Executive summary
Revenue for Q1 2026 was ¥1.51 billion, down 24.75% year-over-year due to VAT policy changes, industry policies, market competition, and channel inventory adjustments.
Net profit attributable to shareholders was ¥316 million, a 43.85% year-over-year decline, mainly from VAT policy impact, strategic business adjustments, and continued R&D investment.
Sequentially, both revenue and net profit improved compared to Q4 2025, reflecting early results from operational transformation.
Financial highlights
Operating cash flow was ¥161 million, down 79.3% year-over-year.
Basic and diluted EPS were ¥0.048, down 43.53% year-over-year.
Gross margin and operating profit margin declined due to lower product prices and higher R&D expenses.
Total assets at quarter-end were ¥37.98 billion, up 0.53% from year-end 2025.
Outlook and guidance
The company will continue to focus on plasma sourcing, innovation in biopharmaceuticals, and digital transformation.
Plans to accelerate new drug launches and expand indications, leveraging the Haier health ecosystem.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Shanghai RAAS Blood Products
- Revenue and profit declined, but plasma expansion and innovation drive future growth.002252
Q4 202527 Mar 2026 - Revenue and profit fell, but cash flow and strategic expansion strengthened future prospects.002252Q2 202522 Dec 2025
- Net profit dropped 26% on flat revenue, with major buybacks and clinical trial advances.002252Q3 202528 Oct 2025
- Revenue and profit rose in Q3 2024 as Haier Group took control and R&D advanced.002252Q3 202413 Jun 2025
- H1 2024 revenue up 9.02% YoY, Haier Group now controls Shanghai RAAS.002252Q2 202413 Jun 2025
- 2024 saw robust profit growth, Haier control, and strategic expansion for Shanghai RAAS.002252Q4 20249 Jun 2025
- Net profit fell 25% in Q1 2025, but strategic acquisitions and buybacks support future growth.002252Q1 20256 Jun 2025
Next Shanghai RAAS Blood Products earnings date
Q2 202628 Aug, 2026
Shanghai RAAS Blood Products
Next Shanghai RAAS Blood Products earnings date
Q2 202628 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage